Skip to main content

12 Result(s)

within Christoph Faul Remove this filter

and

  1. Article

    Open Access

    Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome

    Jan Christian Schroeder, Lucas Mix, Philipp Faustmann… in Bone Marrow Transplantation (2024)

    Download PDF (526 KB) View Article

  2. No Access

    Article

    Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia

    Michaela Kotrova, Antonia Volland, Britta Kehden, Heiko Trautmann… in Leukemia (2020)

  3. No Access

    Article

    Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia

    Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for high-risk myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal prognosis and further thera...

    Corina Schneidawind, Volker Hagmaier, Christoph Faul, Lothar Kanz… in Annals of Hematology (2018)

  4. No Access

    Article

    Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation

    Disease relapse after one or more allogeneic hematopoietic cell transplantations (HCT) represents a therapeutic challenge with all options bearing a significant morbidity and mortality. Haploidentical HCT may ...

    Sebastian P. Haen, Christiane Groh, Michael Schumm, Linus Backert… in Annals of Hematology (2017)

  5. No Access

    Article

    Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies

    Prolonged aplasia and graft failure (GF) represent life-threatening complications after hematopoietic cell transplantation (HCT) requiring suitable biomarkers for early detection and differentiation between GF...

    Sebastian P. Haen, Vicky Eyb, Nora Mirza… in Journal of Cancer Research and Clinical On… (2017)

  6. No Access

    Article

    Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience

    Myelofibrosis (MF) is a rare disease responsible for an increasing ineffective hematopoesis by a progressive fibrosing process in the bone marrow. The only curative treatment option is allogeneic hematopoietic...

    Joerg U. Schmohl, Christiane Groh, Christoph Faul, Wichard Vogel… in Annals of Hematology (2016)

  7. No Access

    Article

    Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies

    We report a retrospective single-center analysis of 112 consecutive patients that underwent allogeneic hematopoietic cell transplantation (HCT) after reduced-intensity conditioning (RIC) with fludarabine (FLU)...

    Dominik Schneidawind, Birgit Federmann, Corina Buechele… in Annals of Hematology (2016)

  8. No Access

    Article

    Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation

    Insufficient production of leukocytes, thrombocytes and erythrocytes after allogeneic peripheral blood stem cell transplantation (PBSCT) represents a life-threatening complication.

    Sebastian P. Haen, Michael Schumm… in Journal of Cancer Research and Clinical On… (2015)

  9. No Access

    Article

    Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia

    Patients with primary refractory or relapsed acute myeloid leukemia (AML) have a dismal prognosis. We report a retrospective single center analysis of aplasia-inducing chemotherapy using fludarabine, cytarabin...

    Dominik Schneidawind, Birgit Federmann, Christoph Faul… in Annals of Hematology (2013)

  10. No Access

    Article

    Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors

    To determine the long-term outcome of patients after allogeneic transplantation of T-cell depleted versus unmanipulated hematopoietic stem cell grafts with respect to incidence of GvHD and overall survival in ...

    Hans-Georg Kopp, Stefan Wirths… in Journal of Cancer Research and Clinical On… (2010)

  11. No Access

    Article

    Total-Body Irradiation—Role and Indications

    Total-body irradiation (TBI) is a key part of the conditioning regimen before hematopoietic stem cell transplantation (HSCT). The exact role of TBI as part of the conditioning regimen is largely unclear. In or...

    Frank Heinzelmann, Helmut Ottinger, Carl-Heinz Müller… in Strahlentherapie und Onkologie (2006)

  12. No Access

    Article

    Low molecular weight heparin for deep vein thrombosis in glioma patients

    The treatment and secondary prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism, a common complication in patients with malignant glioma, has remained controversial. We treated 11 patients with m...

    Friederike Schmidt, Christoph Faul, Johannes Dichgans… in Journal of Neurology (2002)